Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Brown, Patrick
[Clear All Filters]
2015
Sison EAllan R
,
Magoon D
,
Li L
,
Annesley CE
,
Romagnoli B
,
Douglas GJ
,
Tuffin G
,
Zimmermann J
,
Brown P
.
POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity to chemotherapy in pediatric ALL.
Oncotarget. 2015.
PubMed
Google Scholar
2020
Brown P
,
Inaba H
,
Annesley C
,
Beck J
,
Colace S
,
Dallas M
,
DeSantes K
,
Kelly K
,
Kitko C
,
Lacayo N
, et al.
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw. 2020;18(1):81-112.
PubMed
Google Scholar
2022
Pommert L
,
Schafer ES
,
Malvar J
,
Gossai N
,
Florendo E
,
Pulakanti K
,
Heimbruch K
,
Stelloh C
,
Chi Y-Y
,
Sposto R
, et al.
Decitabine and Vorinostat with FLAG Chemotherapy in Pediatric Relapsed/Refractory AML: Report from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium.
Am J Hematol. 2022.
PubMed
Google Scholar
Pollard JA
,
Alonzo TA
,
Gerbing R
,
Brown P
,
Fox E
,
Choi J
,
Fisher B
,
Hirsch B
,
Kahwash S
,
Getz K
, et al.
Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio /ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031.
J Clin Oncol. 2022:JCO2101612.
PubMed
Google Scholar